Invention Grant
- Patent Title: CGRP binding nucleic acids
- Patent Title (中): CGRP结合核酸
-
Application No.: US10513490Application Date: 2003-05-06
-
Publication No.: US07879991B2Publication Date: 2011-02-01
- Inventor: Axel Vater , Christian Maasch , Florian Jarosch , Mathias Bell , Steffen Helmling , Bernd Eschgfäller , Elisabeth Moyroud , Sandra Stark , Sven Klussmann , Thorsten Ruppert , Gregor Bahrenberg , Clemens Gillen , Klaus Schiene
- Applicant: Axel Vater , Christian Maasch , Florian Jarosch , Mathias Bell , Steffen Helmling , Bernd Eschgfäller , Elisabeth Moyroud , Sandra Stark , Sven Klussmann , Thorsten Ruppert , Gregor Bahrenberg , Clemens Gillen , Klaus Schiene
- Applicant Address: DE Berlin
- Assignee: NOXXON Pharma AG
- Current Assignee: NOXXON Pharma AG
- Current Assignee Address: DE Berlin
- Agency: MDIP LLC
- Priority: DE10220188 20020506; DE10251246 20021104
- International Application: PCT/EP03/04746 WO 20030506
- International Announcement: WO03/093472 WO 20031113
- Main IPC: C07H21/04
- IPC: C07H21/04

Abstract:
The invention relates to an antagonist for CGRP and amylin, whereby the antagonist is a nucleic acid and said nucleic acid binds to CGRP or amylin. Said nucleic acid preferably comprises an L-nucleotide.
Public/Granted literature
- US20060183700A1 Cgrp binding nucleic acids Public/Granted day:2006-08-17
Information query